Moreover, researchers identified that NFE2L2 and KEAP1 mutations were only observed in advanced HCC suggesting that these mutations were late events in human liver carcinogenesis 17, 28, 29, 30. This evidence concerns the gene KEAP1 and hepatocellular carcinoma.